Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

6.1K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
6.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

100
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
100
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

94
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
94
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

57
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
57
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

130
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
130

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresis.

Frontiers in immunology·2026
Same author

Enhancing bioactivity of 3D-printed porous scaffolds with self-assembling peptide hydrogels for cartilage tissue engineering.

3D printing in medicine·2026
Same author

Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups.

HemaSphere·2026
Same author

Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and Kdigo 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Belimumab in Systemic Lupus Erythematosus: From B-Cell Biology to Disease Modification.

Journal of clinical medicine·2026
Same journal

Calcimimetic and vitamin D receptor agonist therapy associates with lower mortality and fractures in hemodialysis patients: an international DOPPS analysis.

Clinical kidney journal·2026
Same journal

Cord blood-derived mesenchymal stromal cells in children with steroid-dependent nephrotic syndrome: a prospective phase II study.

Clinical kidney journal·2026
Same journal

CKD as an independent driver of polypharmacy.

Clinical kidney journal·2026
Same journal

Primary hyperoxaluria type 1-current practice in the siRNA era: an ERA Genes & Kidney Working Group survey.

Clinical kidney journal·2026
Same journal

Renal lymphatic vessels correlate with disease activity and progression of IgA nephropathy: a retrospective cohort study.

Clinical kidney journal·2026
Same journal

Multidisciplinary teams in lupus nephritis: where is the evidence for improved outcomes?

Clinical kidney journal·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.9K

Thrombotic microangiopathies assessment: mind the complement.

Miquel Blasco1,2, Elena Guillén1, Luis F Quintana1,2

  • 1Department of Nephrology and Kidney Transplantation, Hospital Clínic, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), University of Barcelona, Barcelona, Spain.

Clinical Kidney Journal
|April 12, 2021
PubMed
Summary
This summary is machine-generated.

Thrombotic microangiopathy (TMA) diagnosis is challenging due to varied causes. Evaluating complement activation is key for diagnosing atypical hemolytic uremic syndrome (aHUS) and improving TMA patient outcomes.

Keywords:
C5b-9 depositscomplement systemendothelial cells (ECs)membrane attack complex (C5b-9)soluble C5b-9thrombotic microangiopathies

More Related Videos

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes
09:58

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Published on: June 17, 2020

5.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.3K

Related Experiment Videos

Last Updated: Nov 9, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.9K
Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes
09:58

Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

Published on: June 17, 2020

5.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.3K

Area of Science:

  • Nephrology
  • Hematology
  • Immunology

Background:

  • Thrombotic microangiopathy (TMA) presents with microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction, often hindering early diagnosis and treatment.
  • While thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS) are well-studied TMAs, aHUS diagnosis requires excluding other causes, delaying effective therapy.
  • Emerging evidence suggests complement system overactivation contributes to TMA progression, impacting various forms of the condition.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for suspected TMA.
  • To emphasize the role of complement evaluation in diagnosing aHUS and understanding its involvement in other TMAs.
  • To highlight the potential of new biomarkers and treatments for improving TMA patient management.

Main Methods:

  • Literature review focusing on diagnostic and therapeutic approaches for TMA.
  • Analysis of the role of complement activation in TMA pathophysiology.
  • Discussion of advancements in diagnostic tools and treatments for TMA.

Main Results:

  • Complement evaluation is a potential tool for inclusive aHUS diagnosis.
  • Understanding complement's role may improve knowledge of its pathophysiological involvement in other TMAs.
  • New complement activation biomarkers and inhibitory treatments are anticipated to enhance TMA patient management.

Conclusions:

  • Early and accurate diagnosis of TMA, particularly aHUS, is critical for timely intervention.
  • Complement system evaluation offers a promising avenue for inclusive TMA diagnosis and understanding disease mechanisms.
  • Advancements in complement-targeted diagnostics and therapeutics are expected to significantly improve patient outcomes in TMA.